Salivary α-Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome.
Martina FanellaEmanuele Cerulli IrelliTommaso AccinniFabio Di FabioCarolina PutottoFederica PulvirentiFrancesco E BellomiCarlo Di BonaventuraGiorgio VivacquaPublished in: Movement disorders clinical practice (2024)
This exploratory study suggests that the parkinsonian phenotype of 22q11.2DS is associated with a reduced concentration of monomeric α-synuclein in biological fluids.
Keyphrases